R. J. Thompson Et Al. , "Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.," The lancet. Gastroenterology & hepatology , vol.7, no.9, pp.830-842, 2022
Thompson, R. J. Et Al. 2022. Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.. The lancet. Gastroenterology & hepatology , vol.7, no.9 , 830-842.
Thompson, R. J., Arnell, H., ARTAN, R., Baumann, U., Calvo, P. L., Czubkowski, P., ... DALGIÇ, B.(2022). Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.. The lancet. Gastroenterology & hepatology , vol.7, no.9, 830-842.
Thompson, Richard Et Al. "Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.," The lancet. Gastroenterology & hepatology , vol.7, no.9, 830-842, 2022
Thompson, Richard J. Et Al. "Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.." The lancet. Gastroenterology & hepatology , vol.7, no.9, pp.830-842, 2022
Thompson, R. J. Et Al. (2022) . "Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.." The lancet. Gastroenterology & hepatology , vol.7, no.9, pp.830-842.
@article{article, author={Richard J Thompson Et Al. }, title={Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.}, journal={The lancet. Gastroenterology & hepatology}, year=2022, pages={830-842} }